Zomedica Corp. (AMEX:ZOM) Q3 2023 Earnings Call Transcript

Page 3 of 3

So we expect to launch those beginning in the first quarter of next year. We should have a full year of those. TRUFORMA will lag a little bit, and that’s because the TRUFORMA cartridges require refrigeration. And so our first priority is to rationalize the distribution network we already have in place, put new distributors in place where we don’t currently have distribution, focus on the products that don’t require refrigeration, and then figure out logistics. And once everybody’s up and running, then we would bring TRUFORMA into that mix. Here’s one, has the company considered partnering with veterinary cage manufacturers to incorporate the VetGuardian technology? And then it talks a little bit more about other opportunities. And let me just say the answer to that is, yes.

And we see that monitoring applying not only to the use cases in the vet’s practice, meaning ICU, post-surgery recovery, and overnight stays, but also extending to boarding kennels, for example, or to, in some cases, places where they’re selling animals or what have you. The ability to, in some way, to monitor pet vitals would be, I think, an advantage in a number of scenarios outside of the sort of classic vet practice and now that we’ve finalized the acquisition of SMP and acquired VetGuardian in total we’re able to look into that and that’s actually pretty encouraging. Let’s see what else we got here. That pretty much takes care of it?

Larry Heaton: Yeah. Okay. All right. Well then let me just say that I know that we’re probably going to get a lot of commentary on some of our discussions today. I would ask you to keep an open mind there and remind you that no reverse split can be approved unilaterally by our board or by the company. That it requires a vote of shareholders. All of you will have an opportunity, those of you who are shareholders, will have an opportunity to weigh in on this as you vote your shares. We would encourage you to vote, regardless of which way you do, because we appreciate the input and the participation and we will communicate often and early along the process, along with data, so that you could see that there have been some examples of where it hasn’t gone awry and maybe you will also provide some data on what happens after you do a stock buyback but with that I would say you know while everyone might not share the same perspective, I think we had a pretty good quarter.

And we’re looking forward to an even better one in the fourth quarter. Thank you for your participation today.

Operator: Thank you. This concludes today’s teleconference. You may disconnect your lines at this time. Thank you for your participation.

Follow Zomedica Corp.

Page 3 of 3